microbiome

Statins, the commonly prescribed class of drugs to reduce cardiovascular disease risk, are identified as a potential microbiota-modulating therapeutic, according to a new study. The microbiome, the genetic material of all microorganisms that live in the human body, is essential for development, immunity and nutrition. Cardiometabolic diseases (CMDs) like heart disease and metabolic disorders such […]